# 2026年2月19日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 经鼻高流量鼻导管氧疗患者肠内营养的安全性研究

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41705878)
**期刊：** Critical care medicine
**PMID：** 41705878
**DOI：** 10.1097/CCM.0000000000007074

### 第一部分 原文与翻译

**英文原标题：** Safety of Enteral Feeding in Patients on High-Flow Nasal Cannula.

> **英文摘要：**
> OBJECTIVES: The goal of this study was to assess the effect of enteral feeding on aspiration risk and progression of respiratory failure in adults on high-flow nasal cannula (HFNC) oxygen therapy. DESIGN: Single-center retrospective cohort study. SETTING: Keck Hospital of the University of Southern California, a tertiary care academic hospital. PATIENTS: Hospitalized adults treated with HFNC between January 1, 2020, and December 31, 2022, were included. Exclusion criteria were chronic total parenteral nutrition, chronic tracheostomy, history of total laryngectomy, and "Do Not Intubate" code status. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The primary outcome was the progression of respiratory failure from HFNC to noninvasive positive pressure ventilation, mechanical ventilation, or extracorporeal membrane oxygenation. We included 220 patients in the primary analysis. The median age was 62.6 years, 54.1% of patients were male, and 43.6% of patients were White. The primary outcome of progression of respiratory failure occurred in 57 patients, of whom 19 (33.3%) were feeding enterally and 38 (66.7%) were NPO at the time of progression. Patients feeding enterally were less likely than those who were NPO to have progression of respiratory failure in a multivariate mixed effects linear regression model (odds ratio [OR], 0.33; 95% CI, 0.18-0.58; p < 0.001). Patients feeding enterally remained less likely to have progression of respiratory failure in a propensity score-matched analysis (OR, 0.30; 95% CI, 0.15-0.58; p < 0.001). CONCLUSIONS: In this single-center, retrospective cohort, enteral nutrition in patients on HFNC was associated with lower risk of progression of respiratory failure and was not associated with increased risk of poor clinical outcomes. Prospective multicenter studies are needed to confirm these findings.

> **中文摘要：**
> 【目的】本研究旨在评估接受经鼻高流量鼻导管（HFNC）氧疗的成人患者进行肠内营养对误吸风险及呼吸衰竭进展的影响。
> 【设计】单中心回顾性队列研究。
> 【地点】南加州大学凯克医院，一所三级医疗教学医院。
> 【患者】纳入了2020年1月1日至2022年12月31日期间接受HFNC治疗的住院成人患者。排除标准包括：长期全胃肠外营养、长期气管切开术、全喉切除术史以及“拒绝插管”状态。
> 【干预措施】无。
> 【测量指标与主要结果】主要结局指标是呼吸衰竭的进展，即从HFNC升级为无创正压通气、机械通气或体外膜肺氧合。主要分析共纳入220名患者。中位年龄为62.6岁，54.1%为男性，43.6%为白人。共有57名患者发生了呼吸衰竭进展的主要结局，其中19人（33.3%）在进展时正在接受肠内营养，38人（66.7%）在进展时处于禁食（NPO）状态。在多变量混合效应线性回归模型中，接受肠内营养的患者发生呼吸衰竭进展的可能性低于禁食患者（比值比 [OR] 0.33；95% CI 0.18-0.58；p < 0.001）。在倾向评分匹配分析中，接受肠内营养的患者发生呼吸衰竭进展的可能性仍然较低（OR 0.30；95% CI 0.15-0.58；p < 0.001）。
> 【结论】在这项单中心回顾性队列研究中，HFNC患者接受肠内营养与较低的呼吸衰竭进展风险相关，且未增加临床预后不良的风险。需要进行前瞻性多中心研究来验证这些发现。

### 第二部分 AI 大师评价

该研究通过回顾性队列分析，重点探讨了重症医学中一个极具争议的话题：HFNC氧疗期间肠内营养的安全性。研究结果有力地挑战了“HFNC患者应常规禁食以防误吸”的传统观念，显示肠内营养不仅安全，且与呼吸功能恶化的风险降低相关。尽管受限于单中心回顾性设计的固有局限性，其采用的多因素回归和倾向评分匹配增强了结论的统计学效力，为临床早期营养支持提供了重要的循证依据。

---

## 2. 抗生素头孢地尔对脂多糖诱导的急性肺损伤的免疫介导作用

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41705816)
**期刊：** Antimicrobial agents and chemotherapy
**PMID：** 41705816
**DOI：** 10.1128/aac.01634-25

### 第一部分 原文与翻译

**英文原标题：** An immune-mediated effect of the antibiotic cefiderocol on LPS-induced acute lung injury.

> **英文摘要：**
> UNLABELLED: This study examines the immune-modulatory effects of cefiderocol in a murine model of lipopolysaccharide (LPS)-induced acute lung injury (ALI). Cefiderocol pretreatment significantly reduced lung tissue damage, lowered pro-inflammatory cytokines, and decreased ferroptosis markers. Its protective effect was comparable to that of the ferroptosis inhibitor ferrostatin-1, while cefepime showed limited efficacy. These findings suggest that cefiderocol has an immuno-mediated role in LPS-induced ALI, potentially by modulating ferroptosis and inflammation, warranting further investigation for sepsis-related complications. IMPORTANCE: This study examines the immune-modulatory effects of cefiderocol in a murine model of LPS-induced acute lung injury (ALI). Cefiderocol pretreatment significantly reduced lung tissue damage, lowered pro-inflammatory cytokines, and decreased ferroptosis markers. Its protective effect was comparable to that of the ferroptosis inhibitor ferrostatin-1, while cefepime showed limited efficacy. These findings suggest that cefiderocol has an immuno-mediated role in LPS-induced ALI, potentially by modulating ferroptosis and inflammation, warranting further investigation for sepsis-related complications.

> **中文摘要：**
> 未标注：本研究探讨了头孢地尔在脂多糖（LPS）诱导的急性肺损伤（ALI）小鼠模型中的免疫调节作用。头孢地尔预处理显著减轻了肺组织损伤，降低了促炎细胞因子水平，并减少了铁死亡标志物。其保护作用与铁死亡抑制剂 ferrostatin-1 相当，而头孢吡肟的疗效有限。这些研究结果表明，头孢地尔在 LPS 诱导的 ALI 中发挥免疫介导作用，可能通过调节铁死亡和炎症实现，值得在败血症相关并发症中进行进一步研究。重要性：本研究探讨了头孢地尔在 LPS 诱导的急性肺损伤（ALI）小鼠模型中的免疫调节作用。头孢地尔预处理显著减轻了肺组织损伤，降低了促炎细胞因子水平，并减少了铁死亡标志物。其保护作用与铁死亡抑制剂 ferrostatin-1 相当，而头孢吡肟的疗效有限。这些研究结果表明，头孢地尔在 LPS 诱导的 ALI 中发挥免疫介导作用，可能通过调节铁死亡和炎症实现，值得在败血症相关并发症中进行进一步研究。

### 第二部分 AI 大师评价

本研究揭示了新型头孢菌素头孢地尔（Cefiderocol）在抗菌活性之外的潜在免疫调节功能。通过LPS诱导的ALI模型，实验证明头孢地尔能有效抑制促炎细胞因子并减少铁死亡相关损伤，其肺保护效力与铁死亡抑制剂Ferrostatin-1相当。该研究不仅发现了头孢地尔的新药理特性，也为治疗败血症相关的急性肺损伤提供了“抗菌+免疫调节”双重机制的新思路，具有较高的临床转化价值。

---

## 3. 雄性偏向表达的Cyp17a2通过稳定STING和降解病毒蛋白介导鱼类抗病毒免疫的性别二态性

**原文链接：** [点击跳转](https://pubmed.ncbi.gov/41705328)
**期刊：** eLife
**PMID：** 41705328
**DOI：** 10.7554/eLife.108048

### 第一部分 原文与翻译

**英文原标题：** Male-biased Cyp17a2 orchestrates antiviral sexual dimorphism in fish via STING stabilization and viral protein degradation.

> **英文摘要：**
> Differences in immunity between males and females in living organisms are generally thought to be due to sex hormones and sex chromosomes, and it is often assumed that males have a weaker immune response. Here, we report that in fish, males exhibit stronger antiviral immune responses, the male-biased gene  as a critical mediator of this enhanced response. First, we observed that male zebrafish exhibit enhanced antiviral resistance compared to females, and notably, zebrafish lack sex chromosomes. Through transcriptomic screening, we found that  was specifically highly expressed in male fish.  knockout males were equivalent to wild-type males in terms of sex organs and androgen secretion, but the ability to upregulate IFN as well as antiviral resistance was greatly reduced. Then, Cyp17a2 is identified as a positive IFN regulator which is located at the endoplasmic reticulum and specifically interacts with and enhances STING-mediated antiviral responses. Mechanistically, Cyp17a2 stabilizes STING expression by recruiting the E3 ubiquitin ligase bloodthirsty-related gene family member 32 (btr32), which facilitates K33-linked polyubiquitination. The capacity of IFN induction of Cyp17a2 was abolished when STING was knocked down. Meanwhile, Cyp17a2 also attenuates viral infection directly to strengthen the antiviral capacity. As an antiviral protein, Cyp17a2 degrades the spring viremia of carp virus (SVCV) P protein by utilizing USP8 to reduce its K33-linked polyubiquitination. These findings reveal a sex-based regulatory mechanism in teleost antiviral immunity, broadening our understanding of sexual dimorphism in immune responses beyond the conventional roles of sex chromosomes and hormones.

> **中文摘要：**
> 生物体雌雄之间的免疫差异通常被认为是由性激素和性染色体引起的，且人们往往假设雄性的免疫反应较弱。在此，我们报道了在鱼类中，雄性表现出更强的抗病毒免疫反应，而雄性偏向表达的基因Cyp17a2是这种增强反应的关键介质。首先，我们观察到与雌性相比，雄性斑马鱼表现出更强的抗病毒抗性，且值得注意的是，斑马鱼缺乏性染色体。通过转录组筛选，我们发现Cyp17a2在雄鱼中特异性高表达。Cyp17a2敲除的雄鱼在性器官和雄激素分泌方面与野生型雄鱼相当，但其上调干扰素（IFN）的能力以及抗病毒抗性大大降低。随后，Cyp17a2被鉴定为一种定位于内质网的正向IFN调节因子，能够特异性地相互作用并增强STING介导的抗病毒反应。从机制上讲，Cyp17a2通过招募E3泛素连接酶btr32（bloodthirsty-related gene family member 32）来稳定STING的表达，从而促进K33连接的多泛素化。当敲低STING时，Cyp17a2诱导IFN的能力消失。同时，Cyp17a2还通过直接减轻病毒感染来增强抗病毒能力。作为一种抗病毒蛋白，Cyp17a2利用USP8减少草鱼春季病毒（SVCV）P蛋白的K33连接多泛素化，进而促进该蛋白降解。这些发现揭示了硬骨鱼抗病毒免疫中的一种基于性别的调节机制，拓宽了我们对免疫反应性别二态性的理解，使其超越了性染色体和性激素的传统作用。

### 第二部分 AI 大师评价

该研究挑战了“雄性免疫反应较弱”的传统观念，发现在缺乏性染色体的斑马鱼中，雄性具有更强的抗病毒抗性。研究详细阐明了雄性偏向表达基因Cyp17a2通过招募btr32稳定STING表达以及利用USP8降解SVCV病毒P蛋白的双重分子机制。该成果不仅揭示了不依赖于性激素和性染色体的免疫性别差异新机制，也为脊椎动物抗病毒免疫二态性的演化提供了重要见解。

---

## 4. 综合抗生素管理计划对农村医疗机构急性呼吸道感染抗生素处方的影响：一项集群随机对照试验

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41703293)
**期刊：** Nature medicine
**PMID：** 41703293
**DOI：** 10.1038/s41591-026-04222-y

### 第一部分 原文与翻译

**英文原标题：** Effects of a comprehensive antibiotic stewardship program on antibiotic prescribing for acute respiratory infections in rural facilities: a cluster randomized trial.

> **英文摘要：**
> Antimicrobial resistance is driven by inappropriate use of antibiotics for acute respiratory infections (ARIs), which is a major challenge in primary care in low- and middle-income countries. Here we conducted a pragmatic, cluster randomized controlled trial in 34 township hospitals in two rural counties of Guangdong, China, to evaluate whether a digitally enabled stewardship program could reduce antibiotic prescribing. The intervention combined training and guidelines for doctors; concise, evidence-based guidelines embedded in the electronic medical record with point-of-care prompts; monthly prescribing peer review feedback for doctors; and patient education delivered through a smartphone app. Control is usual care with no inputs. During the 12-month implementation period (1 March 2020 to 28 February 2021), we analyzed 97,239 eligible consultations for ARIs. The primary outcome was whether a consultation resulted in any antibiotics being prescribed. This outcome was met: antibiotics were prescribed in 26% (14,521/54,799) of intervention consultations compared to 71% (30,340/42,440) of control consultations, yielding an adjusted risk difference of -39 percentage points (95% confidence interval: -47 to -29; P < 0.001). There was no evidence of increased harm, as 30-day hospitalization rates for respiratory illness or sepsis did not differ between groups (adjusted risk difference, 0.2 percentage points; 95% confidence interval: -0.3 to 0.6). A comprehensive stewardship program can substantially reduce inappropriate antibiotic prescribing for ARIs in rural primary care facilities in China without compromising patient safety. Trial registration: ISRCTN96892547 .

> **中文摘要：**
> 抗生素耐药性主要由急性呼吸道感染（ARIs）中抗生素的不当使用驱动，这在低中收入国家的基层医疗中是一个重大挑战。本研究在中国广东两个农村县的34家乡镇卫生院进行了一项务实的集群随机对照试验，以评估数字化赋能的管理计划是否能减少抗生素处方。干预措施结合了针对医生的培训和指南；嵌入电子病历系统的简洁循证指南及其床旁提示；对医生每月的处方同行评议反馈；以及通过智能手机应用程序提供的患者教育。对照组为常规护理，不进行任何干预。在为期12个月的实施期间（2020年3月1日至2021年2月28日），我们分析了97,239例符合条件的急性呼吸道感染咨询。主要结局指标是咨询是否导致了抗生素处方。研究达到了该主要结局：干预组咨询的抗生素处方率为26%（14,521/54,799），而对照组为71%（30,340/42,440），调整后的风险差异为-39个百分点（95%置信区间：-47至-29；P < 0.001）。没有证据表明干预会增加危害，因为两组间呼吸道疾病或败血症的30天住院率没有差异（调整后的风险差异为0.2个百分点；95%置信区间：-0.3至0.6）。综合管理计划可以在不损害患者安全的情况下，大幅减少中国农村基层医疗机构急性呼吸道感染的不当抗生素处方。试验注册号：ISRCTN96892547。

### 第二部分 AI 大师评价

本研究针对全球公共卫生难题——抗生素滥用，在中国农村基层医疗环境下开展了大规模集群随机对照试验。通过整合数字化临床决策支持、同行评议及患者教育等多维干预手段，研究成功将急性呼吸道感染的抗生素处方率显著降低了39个百分点，且充分证实了干预措施的安全性。其创新性在于利用数字化工具实现了在资源有限地区的高效管理闭环，为中低收入国家遏制抗生素耐药性提供了极具参考价值的实证方案。

---

## 5. 二肽基肽酶4抑制通过恢复肺-子宫轴的免疫稳态减轻妊娠病理

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41702893)
**期刊：** Nature communications
**PMID：** 41702893
**DOI：** 10.1038/s41467-026-69620-9

### 第一部分 原文与翻译

**英文原标题：** Dipeptidylpeptidase 4 inhibition attenuates gestational pathologies via immune homeostasis restoration in the pulmonary-uterine axis.

> **英文摘要：**
> Respiratory viral infections during pregnancy threaten maternal pulmonary health and fetal development, however the mechanisms linking lung infection to distant uterine immune disruption remain unclear. Here, we demonstrate that respiratory viral infection attenuates uterine immune activation, impairing vascular remodeling and trophoblast invasion, which compromises embryonic growth. Treatment with the dipeptidylpeptidase 4 (DPP4) inhibitor sitagliptin restores immune homeostasis in both the lung and uterus, markedly reducing pregnancy complications. Mechanistically, while pulmonary infection expands interleukin-1 receptor type 2-expressing (IL1R2⁺) CD11b⁺ myeloid cells in the lung, this expansion is attenuated by DPP4 inhibition. These cells migrate to the decidua and disrupt pregnancy-maintaining immune signaling. Single-cell RNA sequencing confirms accumulation of IL1R2⁺ regulatory macrophages at both sites. Genetic Il1r2 ablation similarly reduces uterine IL1R2⁺ cells and restores gestation. This study reveals a lung-uterus immune axis and identifies DPP4 inhibition as a dual-organ therapeutic strategy against viral-induced pregnancy pathology.

> **中文摘要：**
> 妊娠期间的呼吸道病毒感染威胁母体肺部健康和胎儿发育，然而将肺部感染与远端子宫免疫失调联系起来的机制尚不清楚。在这里，我们证明呼吸道病毒感染会削弱子宫免疫激活，损害血管重塑和滋养层细胞侵袭，从而损害胚胎生长。使用二肽基肽酶4（DPP4）抑制剂西格列汀治疗可恢复肺部和子宫的免疫稳态，显著减少妊娠并发症。从机制上讲，虽然肺部感染会导致肺部表达白细胞介素-1受体2型（IL1R2⁺）的CD11b⁺髓系细胞扩增，但这种扩增会被DPP4抑制所削弱。这些细胞迁移到蜕膜并破坏维持妊娠的免疫信号。单细胞RNA测序证实了IL1R2⁺调节性巨噬细胞在两个部位的积累。遗传性Il1r2敲除同样减少了子宫IL1R2⁺细胞并恢复了妊娠。本研究揭示了肺-子宫免疫轴，并确定DPP4抑制是针对病毒诱导的妊娠病理的双器官治疗策略。

### 第二部分 AI 大师评价

本研究阐明了呼吸道病毒感染通过“肺-子宫轴”干扰妊娠稳态的分子机制，重点揭示了IL1R2⁺调节性巨噬细胞在肺部扩增并迁移至子宫蜕膜，从而破坏血管重塑和滋养层侵袭的过程。研究创新性地提出应用DPP4抑制剂西格列汀作为双器官保护策略，能够有效恢复免疫平衡并减轻妊娠并发症。该发现不仅为理解呼吸道感染导致的母胎健康风险提供了新视角，也为预防相关妊娠病理提供了潜在的临床药物干预方案。

---

## 6. CD57+ CD8 T细胞亚群将细胞毒性T细胞的细胞毒性与系统性硬化症纤维化肺病相联系

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41701649)
**期刊：** The Journal of clinical investigation
**PMID：** 41701649
**DOI：** 10.1172/JCI194288

### 第一部分 原文与翻译

**英文原标题：** A CD57+ CD8 T cell subset links cytotoxic T cell cytotoxicity to fibrotic lung disease in systemic sclerosis.

> **英文摘要：**
> Interstitial lung disease (ILD) is a major cause of morbidity and mortality in systemic sclerosis (SSc); however, the immunopathologic mechanisms driving lung disease in SSc are unclear. T cells have been implicated as a likely driver of lung injury in SSc. Here, we have evaluated T cells in the blood of patients with SSc-ILD and identified a specific population of cytotoxic CD8 T cells that is expanded in SSc-ILD patients. Cytotoxic effector memory CD8 T cells marked by CD57 expression are preferentially expanded in SSc-ILD patients compared to SSc patients without ILD and controls and show prominent clonal expansion. These CD57+ T effector memory (TEM) cells differ from T effector memory cells re-expressing CD45RA (TEMRA) transcriptomically and functionally, with cytotoxic function that is enhanced by CD155 engagement of the costimulatory receptor CD226. We performed immunostaining of lung tissue samples obtained from independent SSc-ILD patients (biopsy or explant) and confirmed the presence of CD57+ TEM. In parallel, we analyzed publicly available lung scRNA-seq datasets from multiple ILD cohorts and identified endothelial cells as a likely source of CD155 to activate CD57+ cytotoxic T cells. Together, the results implicate a CD57+ cytotoxic CD8 T cell population as a potential mediator of lung injury in SSc-ILD.

> **中文摘要：**
> 间质性肺病（ILD）是系统性硬化症（SSc）致残和死亡的主要原因；然而，驱动SSc肺部疾病的免疫病理机制尚不明确。T细胞一直被认为是SSc肺损伤的潜在驱动因素。在本研究中，我们评估了SSc-ILD患者血液中的T细胞，并鉴定出一群在SSc-ILD患者中显著扩增的特异性细胞毒性CD8 T细胞。与不伴有ILD的SSc患者及对照组相比，以CD57表达为标志的细胞毒性效应记忆CD8 T细胞在SSc-ILD患者中优先扩增，并表现出显著的克隆性扩增。这些CD57+效应记忆T细胞（TEM）在转录组和功能上均不同于重新表达CD45RA的效应记忆T细胞（TEMRA），其细胞毒性功能可通过CD155与共刺激受体CD226的结合而增强。我们对来自独立SSc-ILD患者（活检或移植肺）的肺组织样本进行了免疫染色，证实了CD57+ TEM的存在。同时，我们分析了来自多个ILD队列的公开肺部单细胞RNA测序（scRNA-seq）数据集，并将内皮细胞鉴定为激活CD57+细胞毒性T细胞的CD155可能来源。总之，这些结果表明CD57+细胞毒性CD8 T细胞群是SSc-ILD肺损伤的潜在介质。

### 第二部分 AI 大师评价

该研究通过临床样本分析和单细胞测序技术，成功鉴定出CD57+ CD8 T效应记忆细胞（TEM）是系统性硬化症相关间质性肺病（SSc-ILD）的关键驱动因素。研究不仅揭示了该细胞亚群在转录组学和功能上不同于典型的TEMRA细胞，还阐明了其通过CD155-CD226共刺激途径增强细胞毒性的免疫机制。这一发现通过肺组织原位验证和公共数据库交叉分析，增强了结论的可靠性，为未来针对SSc-ILD的免疫靶向治疗提供了精准的细胞和分子靶点。

---

## 7. 急性脑损伤患者机械通气设置：超低动态驱动压能带来更好的预后吗？

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41701326)
**期刊：** Intensive care medicine
**PMID：** 41701326
**DOI：** 10.1007/s00134-026-08343-3

### 第一部分 原文与翻译

**英文原标题：** Setting mechanical ventilation in patients with acute brain injury: ultra-low dynamic driving pressure for better outcomes?

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 暂无摘要。

### 第二部分 AI 大师评价

本文聚焦于急性脑损伤（ABI）患者机械通气管理的核心临床难点，探讨了超低动态驱动压在改善该类患者预后中的潜在应用价值。文章深入分析了在保障神经系统稳定性与实施肺保护性通气之间的复杂权衡，强调了精准调节通气参数对减少二次脑损伤的重要性。尽管缺乏详细摘要，但其标题所揭示的生理学视角对于神经重症领域的个体化通气策略制定具有高度的启发性和临床指导意义。

---

## 8. 非心脏手术中的术中血压管理：基于当前证据的叙述性综述

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41701325)
**期刊：** Intensive care medicine
**PMID：** 41701325
**DOI：** 10.1007/s00134-026-08326-4

### 第一部分 原文与翻译

**英文原标题：** Intraoperative blood pressure management in noncardiac surgery: a narrative review based on current evidence.

> **英文摘要：**
> PURPOSE: Blood pressure is closely monitored during anaesthesia, yet the optimal intraoperative target remains uncertain. This narrative review synthesizes contemporary observational and randomized evidence and explores emerging strategies for individualized haemodynamic management. METHODS: We reviewed major observational cohort studies, randomized controlled trials (RCTs), consensus statements, and recent technological developments addressing intraoperative hypotension, MAP thresholds, and strategies to prevent perioperative organ injury in adult noncardiac surgery. RESULTS: Large observational datasets consistently demonstrate graded, duration-dependent associations between intraoperative MAP 60-70 mmHg and postoperative myocardial injury, acute kidney injury, and mortality . These findings have informed international recommendations to avoid MAP below 60-65 mmHg. However, contemporary multicentre RCTs enrolling more than 13,000 patients show that targeting higher or individualized MAP thresholds does not improve patient-centred outcomes compared with routine care (typically MAP ≥ 65 mmHg) . Only one small trial reported benefit with individualized systolic targets. Emerging evidence suggests that hypotension reflects heterogeneous haemodynamic endotypes (vasodilation, hypovolaemia, myocardial depression, bradycardia), potentially explaining why uniform pressure targets fail to improve outcomes. Continuous blood pressure monitoring, proactive norepinephrine infusion, predictive analytics, and closed-loop vasopressor systems reliably reduce hypotension exposure, although definitive outcome benefits remain unproven. CONCLUSIONS: Observational and randomized data are concordant: MAP ≥ 60-65 mmHg appears sufficient for most noncardiac surgical patients. Future progress will likely depend on mechanistic endotyping, integration of advanced monitoring, and precision-guided haemodynamic strategies rather than escalation of universal MAP targets alone.

> **中文摘要：**
> 目的：麻醉期间需密切监测血压，但最佳术中目标仍不确定。本叙述性综述综合了当代的观察性及随机对照证据，并探讨了针对个体化血流动力学管理的新兴策略。方法：我们回顾了主要的观察性队列研究、随机对照试验（RCTs）、共识声明，以及针对成人非心脏手术中术中低血压、平均动脉压（MAP）阈值和预防围手术期器官损伤策略的最新技术发展。结果：大型观察性数据集一致显示，术中 MAP 在 60-70 mmHg 之间与术后心肌损伤、急性肾损伤及死亡率存在分级且具有持续时间依赖性的关联。这些发现为避免 MAP 低于 60-65 mmHg 的国际建议提供了依据。然而，纳入超过 13,000 名患者的当代多中心 RCT 显示，与常规护理（通常 MAP ≥ 65 mmHg）相比，设定更高或个体化的 MAP 阈值并不能改善以患者为中心的结果。仅有一项小型试验报告了个体化收缩压目标的益处。新兴证据表明，低血压反映了异质性的血流动力学内表型（血管扩张、血容量不足、心肌抑制、心动过缓），这可能解释了为什么统一的血压目标无法改善预后。连续血压监测、前瞻性去甲肾上腺素输注、预测性分析和闭环血管收缩药物系统能够可靠地减少低血压暴露，尽管其明确的结局获益尚未得到证实。结论：观察性与随机数据是一致的：对于大多数非心脏手术患者，MAP ≥ 60-65 mmHg 似乎已经足够。未来的进展可能取决于机制内表型分析、先进监测技术的整合以及精准引导的血流动力学策略，而非单纯提高普遍的 MAP 目标。

### 第二部分 AI 大师评价

本文对非心脏手术术中血压管理的证据进行了深度整合，精准指出了观察性研究与大型随机对照试验（RCT）在临床结局上的差异。评价认为，尽管低血压与器官损伤的相关性明确，但盲目提升通用的MAP目标并不能带来额外获益。文章的创新之处在于提出了低血压异质性“内表型”的概念，并前瞻性地讨论了预测性分析和闭环系统等新技术。其局限性在于目前的证据仍无法为特定高危亚组提供明确的个体化干预阈值，强调了从“统一压力目标”向“精准血流动力学管理”转型的必要性。

---

速递结束，祝您工作愉快！